Metropolitan Stock Exchange is set to commence trading operations within two weeks, having secured ₹1,240 crore in funding across two tranches (December 2024 and August 2025) backed by strategic investments from major brokers Groww and Zerodha, signalling institutional confidence in breaking the NSE–BSE duopoly.
MSE's liquidity enhancement strategy deploys market makers across approximately 130 stocks, building on its MCX Stock Exchange legacy (2013 Liquidity Enhancement Scheme with three market makers for 50 liquid securities), aimed at ensuring consistent quote availability and market depth from operational launch.
NSE dominates with 90–92% cash segment share, 95% stock F&O share, and 80% index F&O share; BSE holds 8–10% cash, 5% stock F&O, and 20% index F&O, representing a formidable structural moat that analysts suggest will be difficult for MSE to penetrate despite substantial capital and broker backing.
SEBI's 2025 rule limiting weekly equity derivatives expiries to two per segment (NSE Tuesday Nifty 50, BSE Thursday Sensex) may constrain MSE's derivatives market entry but could present innovation opportunities in alternative trading segments; regulatory arbitrage and participant acquisition will be critical success factors.
